tiprankstipranks
Trending News
More News >
Kane Biotech (TSE:KNE)
:KNE
Canadian Market

Kane Biotech (KNE) Revenue

Compare
1 Followers

Kane Biotech Revenue

Kane Biotech had a revenue of 125.86K in the quarter ending Dec 31, 2024, with -90.19%. This bring the company's revenue in the last twelve months to 2.08M, Decreased 57.41%. In the fiscal year ending Dec 31, 2024, Kane Biotech had annual revenue of 2.08M with 1296.75% growth.
Revenue (ttm)
2.08M
Revenue Growth
P/S Ratio
4.38
Revenue/Employee
Employees
Market Cap
C$9.12M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
2.08M1.93M+1,296.75%
Dec 31, 2023
148.98K-2.52M-94.42%
Dec 31, 2022
2.67M1.06M+65.97%
Dec 31, 2021
1.61M266.20K+19.84%
Dec 31, 2020
1.34M-351.95K-20.78%
Dec 31, 2019
1.69M1.19M+234.51%
Dec 31, 2018
506.27K-529.03K-51.10%
Dec 31, 2017
1.04M790.55K+322.99%
Dec 31, 2016
244.76K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis